Repligen Corporation News
10 must-know biotech stock events to close out 2016
Important clinical trial results in Alzheimer's, cancer and Crohn's disease and a big FDA decision for Sarepta are expected before the end of the year.
Trade-Ideas: Repligen (RGEN) Is Today's Weak On High Relative Volume Stock
Trade-Ideas LLC identified Repligen (RGEN) as a weak on high relative volume candidate
Insider Trading Alert - RGEN, DVA And FLT Traded By Insiders
Stocks with insider trader activity include RGEN, DVA and FLT
Trade-Ideas: Repligen (RGEN) Is Today's New Lifetime High Stock
Trade-Ideas LLC identified Repligen (RGEN) as a new lifetime high candidate
BP Among Leaders of Fair Value Increases by Morningstar
In the energy sector, 25% of the companies covered by Morningstar garnered fair-value increases of more than 10%.
Nvidia Stock: Investors Are Buying the Dip. Where From Here?
Nvidia stock is being bought on the dip. Here's how traders should approach it now.
Broadcom Agrees to Buy VMware in $61 Billion Cash-and-Stock Cloud Software Deal
"Combining our assets and talented team with Broadcom's existing enterprise software portfolio creates a remarkable enterprise software player," said VMware CEO Raghu Raghuram.